Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 350 of 2228 entries
View as:

BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01314105 Org: User:
Start: 03/15/11 End: 04/04/16 Due: 04/04/17

Bioavailability of BIBR 953 ZW After BIBR 1048 (Oral Pro-drug of BIBR 953 ZW) Administered as Hydroxypropyl Methylcellulose (HPMC) Polymorph II Capsule Relative to HPMC Polymorph I Capsule in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT02170974 Org: User:
Start: 07/31/04 End: - Due: -

Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02589639 Org: User:
Start: 10/28/15 End: 01/05/18 Due: 01/05/19

This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT03259464 Org: User:
Start: 09/04/17 End: 05/26/18 Due: 05/26/19

A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT06367153 Org: User:
Start: 05/15/24 End: 08/20/24 Due: 08/20/25

Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone

Phase: N/A Priority: Normal
NCT ID: NCT01637922 Org: User:
Start: 08/31/12 End: 11/30/12 Due: 11/30/13

A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction

Phase: N/A Priority: Normal
NCT ID: NCT05013385 Org: User:
Start: 11/09/21 End: 05/31/22 Due: 05/31/23

Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives

Phase: N/A Priority: Normal
NCT ID: NCT00539487 Org: User:
Start: 01/31/07 End: - Due: -

Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or Tacrolimus

Phase: N/A Priority: Normal
NCT ID: NCT02016625 Org: User:
Start: 12/31/13 End: 04/30/14 Due: 04/30/15

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT00097799 Org: User:
Start: 12/31/04 End: - Due: -

Observational Prospective Study to Evaluate AEs, Risk Factors and Drug Utilization of BUSCAPINA COMPOSITUM N in Adults From Metropolitan Lima

Phase: N/A Priority: Normal
NCT ID: NCT02910167 Org: User:
Start: 10/15/16 End: 02/20/17 Due: 02/20/18

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01277523 Org: User:
Start: 01/31/11 End: 10/31/13 Due: 10/31/14

Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age

Phase: N/A Priority: Normal
NCT ID: NCT02223260 Org: User:
Start: 09/30/14 End: 02/29/16 Due: 02/28/17

Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00796614 Org: User:
Start: 01/31/08 End: 02/28/09 Due: 02/28/10

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1015550 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01594515 Org: User:
Start: 05/31/12 End: 09/30/12 Due: 09/30/13

Single Rising Dose Study of BI 201335 ZW in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02182271 Org: User:
Start: 10/31/04 End: - Due: -

Bioavailability of BIBR 953 ZW in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02170766 Org: User:
Start: 10/31/00 End: - Due: -

Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02453555 Org: User:
Start: 05/14/15 End: 03/27/17 Due: 03/27/18

Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01342484 Org: User:
Start: 04/30/11 End: 02/29/16 Due: 02/28/17

Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01480648 Org: User:
Start: 11/30/11 End: - Due: -

Observational Study to Assess a 6-months Treatment With Gladem

Phase: N/A Priority: Normal
NCT ID: NCT02231268 Org: User:
Start: 09/30/00 End: - Due: -

Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT01969721 Org: User:
Start: 10/31/13 End: 02/28/15 Due: 02/28/16

Bioavailability Study of Ranitidine Hydrochloride (Maximum Strength ZANTAC 150®) Compared to Two Different 150 mg Ranitidine Hydrochloride Oral Disintegrating Tablet (ODT) in Fasting, Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02195804 Org: User:
Start: 05/31/09 End: - Due: -

Study of Relative Bioavailability of Mobic Manufactured in China in Comparison With Mobic Manufactured in Germany in Chinese Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183142 Org: User:
Start: 03/31/01 End: - Due: -

Safety and Tolerability Study of BIBF 1120 as Intravenous Infusion and Absolute Bioavailability of BIBF 1120 as Soft Gelatine Capsule in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02182258 Org: User:
Start: 06/30/09 End: - Due: -